CA2139107A1 - Methode de stimulation du systeme immunitaire - Google Patents
Methode de stimulation du systeme immunitaireInfo
- Publication number
- CA2139107A1 CA2139107A1 CA002139107A CA2139107A CA2139107A1 CA 2139107 A1 CA2139107 A1 CA 2139107A1 CA 002139107 A CA002139107 A CA 002139107A CA 2139107 A CA2139107 A CA 2139107A CA 2139107 A1 CA2139107 A1 CA 2139107A1
- Authority
- CA
- Canada
- Prior art keywords
- poultry
- reuteri
- hatch
- lactobacillus reuteri
- salmonella
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 19
- 210000000987 immune system Anatomy 0.000 title abstract description 8
- 230000004936 stimulating effect Effects 0.000 title description 4
- 241000186604 Lactobacillus reuteri Species 0.000 claims abstract description 53
- 244000144977 poultry Species 0.000 claims abstract description 31
- 229940001882 lactobacillus reuteri Drugs 0.000 claims abstract description 19
- 210000004027 cell Anatomy 0.000 claims abstract description 12
- 230000000694 effects Effects 0.000 claims description 14
- AKXKFZDCRYJKTF-UHFFFAOYSA-N 3-Hydroxypropionaldehyde Chemical compound OCCC=O AKXKFZDCRYJKTF-UHFFFAOYSA-N 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 230000001965 increasing effect Effects 0.000 claims description 6
- 230000003393 splenic effect Effects 0.000 claims description 6
- 238000011161 development Methods 0.000 claims description 5
- 230000004044 response Effects 0.000 claims description 5
- 108010047620 Phytohemagglutinins Proteins 0.000 claims description 4
- 210000000822 natural killer cell Anatomy 0.000 claims description 4
- 230000001885 phytohemagglutinin Effects 0.000 claims description 4
- NLMDJJTUQPXZFG-UHFFFAOYSA-N 1,4,10,13-tetraoxa-7,16-diazacyclooctadecane Chemical compound C1COCCOCCNCCOCCOCCN1 NLMDJJTUQPXZFG-UHFFFAOYSA-N 0.000 claims 3
- 230000000881 depressing effect Effects 0.000 claims 3
- MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical compound OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 claims 1
- 235000013594 poultry meat Nutrition 0.000 abstract description 23
- 241001465754 Metazoa Species 0.000 abstract description 20
- 241000287828 Gallus gallus Species 0.000 abstract description 15
- 235000013330 chicken meat Nutrition 0.000 abstract description 14
- 210000001744 T-lymphocyte Anatomy 0.000 abstract description 10
- 230000009286 beneficial effect Effects 0.000 abstract description 6
- 241000286209 Phasianidae Species 0.000 abstract description 5
- 210000002540 macrophage Anatomy 0.000 abstract description 4
- 230000028993 immune response Effects 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract 2
- 210000003719 b-lymphocyte Anatomy 0.000 abstract 1
- 241000271566 Aves Species 0.000 description 23
- 238000011282 treatment Methods 0.000 description 15
- 210000001035 gastrointestinal tract Anatomy 0.000 description 10
- 241000607142 Salmonella Species 0.000 description 7
- 244000005700 microbiome Species 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 6
- 230000035882 stress Effects 0.000 description 6
- 241000186660 Lactobacillus Species 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 210000003024 peritoneal macrophage Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000005867 T cell response Effects 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000003405 ileum Anatomy 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 239000006041 probiotic Substances 0.000 description 3
- 235000018291 probiotics Nutrition 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 210000000051 wattle Anatomy 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 206010053613 Type IV hypersensitivity reaction Diseases 0.000 description 2
- 239000005862 Whey Substances 0.000 description 2
- 102000007544 Whey Proteins Human genes 0.000 description 2
- 108010046377 Whey Proteins Proteins 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 210000001198 duodenum Anatomy 0.000 description 2
- 244000144992 flock Species 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 239000003226 mitogen Substances 0.000 description 2
- 230000003562 morphometric effect Effects 0.000 description 2
- 238000013425 morphometry Methods 0.000 description 2
- 230000000529 probiotic effect Effects 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000005951 type IV hypersensitivity Effects 0.000 description 2
- 208000027930 type IV hypersensitivity disease Diseases 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- RZSYLLSAWYUBPE-UHFFFAOYSA-L Fast green FCF Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC(O)=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 RZSYLLSAWYUBPE-UHFFFAOYSA-L 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010025885 Glycerol dehydratase Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241000736262 Microbiota Species 0.000 description 1
- YJQPYGGHQPGBLI-UHFFFAOYSA-N Novobiocin Natural products O1C(C)(C)C(OC)C(OC(N)=O)C(O)C1OC1=CC=C(C(O)=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C YJQPYGGHQPGBLI-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010039438 Salmonella Infections Diseases 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 208000027697 autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency Diseases 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000019751 broiler diet Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000008645 cold stress Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000009699 differential effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 235000014105 formulated food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- 208000024908 graft versus host disease Diseases 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000001744 histochemical effect Effects 0.000 description 1
- 230000028996 humoral immune response Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000005024 intraepithelial lymphocyte Anatomy 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000001630 jejunum Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000000207 lymphocyte subset Anatomy 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 229960000210 nalidixic acid Drugs 0.000 description 1
- MHWLWQUZZRMNGJ-UHFFFAOYSA-N nalidixic acid Chemical compound C1=C(C)N=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 MHWLWQUZZRMNGJ-UHFFFAOYSA-N 0.000 description 1
- 229910052754 neon Inorganic materials 0.000 description 1
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 1
- 229960002950 novobiocin Drugs 0.000 description 1
- YJQPYGGHQPGBLI-KGSXXDOSSA-N novobiocin Chemical compound O1C(C)(C)[C@H](OC)[C@@H](OC(N)=O)[C@@H](O)[C@@H]1OC1=CC=C(C(O)=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C YJQPYGGHQPGBLI-KGSXXDOSSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000009894 physiological stress Effects 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000007115 recruitment Effects 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 206010039447 salmonellosis Diseases 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000002992 thymic effect Effects 0.000 description 1
- 230000025366 tissue development Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000002476 tumorcidal effect Effects 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/173—Reuteri
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Microbiology (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Physiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90420092A | 1992-06-25 | 1992-06-25 | |
| US07/904,200 | 1992-06-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2139107A1 true CA2139107A1 (fr) | 1994-01-06 |
Family
ID=25418757
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002139107A Abandoned CA2139107A1 (fr) | 1992-06-25 | 1993-06-23 | Methode de stimulation du systeme immunitaire |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0648124A4 (fr) |
| AU (1) | AU4647993A (fr) |
| CA (1) | CA2139107A1 (fr) |
| WO (1) | WO1994000139A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5534253A (en) * | 1995-06-07 | 1996-07-09 | Biogaia Ab | Method of treating enteropathogenic bacterial infections in poultry |
| EP1567018B1 (fr) * | 2002-10-18 | 2009-07-01 | Biogaia Ab | Procede permettant de renforcer la fonction immunitaire chez les mammiferes au moyen de souches de lactobacillus reuteri |
| KR100887822B1 (ko) * | 2005-03-10 | 2009-03-09 | 바이오가이아 에이비 | 락토바실러스 루테리 균주를 이용하여 포유동물에서 면역기능을 향상시키는 방법 |
| US20060251634A1 (en) * | 2005-05-06 | 2006-11-09 | Ho-Jin Kang | Method of improving immune function in mammals using lactobacillus strains with certain lipids |
| KR100887819B1 (ko) | 2008-10-13 | 2009-03-09 | 바이오가이아 에이비 | 락토바실러스 루테리 균주를 이용하여 포유동물에서 면역 기능을 향상시키는 방법 |
| JP2010280664A (ja) * | 2010-07-02 | 2010-12-16 | Biogaia Ab | ラクトバチルス・リューテリ（Ｌａｃｔｏｂａｃｉｌｌｕｓｒｅｕｔｅｒｉ）株を用いる哺乳類における免疫機能の改善方法 |
| CN117814356B (zh) * | 2024-01-19 | 2024-11-15 | 广东省农业科学院动物科学研究所 | 罗伊氏乳杆菌在提高高温环境条件下肉鸡采食量和生长性能中的应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2100774C (fr) * | 1991-01-28 | 2002-11-26 | Ivan A. Casas-Perez | Additif pour l'alimentation animale |
-
1993
- 1993-06-23 CA CA002139107A patent/CA2139107A1/fr not_active Abandoned
- 1993-06-23 EP EP93916715A patent/EP0648124A4/fr not_active Withdrawn
- 1993-06-23 AU AU46479/93A patent/AU4647993A/en not_active Abandoned
- 1993-06-23 WO PCT/US1993/006014 patent/WO1994000139A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1994000139A1 (fr) | 1994-01-06 |
| AU4647993A (en) | 1994-01-24 |
| EP0648124A4 (fr) | 1996-05-08 |
| EP0648124A1 (fr) | 1995-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gharib Naseri et al. | Comparison of the effects of probiotic, organic acid and medicinal plant on Campylobacter jejuni challenged broiler chickens | |
| Bailey et al. | Effect of fructooligosaccharide on Salmonella colonization of the chicken intestine | |
| Barrow | Probiotics for chickens | |
| Olsson et al. | Intestinal colonization potential of turbot (Scophthalmus maximus)-and dab (Limanda limanda)-associated bacteria with inhibitory effects against Vibrio anguillarum | |
| Mead | Prospects for ‘competitive exclusion’treatment to control salmonellas and other foodborne pathogens in poultry | |
| Stavric et al. | 10 Microbial probiotics for pigs and poultry | |
| Hinton Jr et al. | Physical, chemical, and microbiological changes in the crop of broiler chickens subjected to incremental feed withdrawal | |
| AU2004305120B2 (en) | Methods of use of probiotic Lactobacilli for companion animals | |
| Impey et al. | Fate of salmonellas in the alimentary tract of chicks pre‐treated with a mature caecal microflora to increase colonization resistance | |
| WO1994003195A1 (fr) | Probiotique d'elimination de la salmonelle | |
| US5458875A (en) | In ovo method for delivering Lactobacillus reuteri to the gastrointestinal tract of poultry | |
| Aho et al. | Competitive exclusion of campylobacters from poultry with K-bacteria and Broilact® | |
| AU2012334962A1 (en) | Lactic acid bacteria and their use as dietary supplementals for poultry | |
| US20050031732A1 (en) | Health and/or nutritional status of an aquatic animal | |
| Strompfova et al. | New probiotic strain Lactobacillus fermentum AD1 and its effect in Japanese quail | |
| Roy et al. | Influence of a propionic acid feed additive on performance of turkey poults with experimentally induced poult enteritis and mortality syndrome | |
| EP1715755B1 (fr) | Utilisation de bacteries vivantes permettant de promouvoir la croissance des animaux | |
| Barrow | Further observations on the effect of feeding diets containing avoparcin on the excretion of salmonellas by experimentally infected chickens | |
| CA2139107A1 (fr) | Methode de stimulation du systeme immunitaire | |
| US20140037605A1 (en) | Anticoccidial composition | |
| Spring | Understanding the development of the avian gastrointestinal microflora: an essential key for developing competitive exclusion products. | |
| AU1365392A (en) | Feed additive and method | |
| Promsopone et al. | Evaluation of an avian-specific probiotic and Salmonella typhimurium-specific antibodies on the colonization of Salmonella typhimurium in broilers | |
| ZIPRIN et al. | Comparison of probiotics maintained by in vivo passage through laying hens and broilers | |
| FI112374B (fi) | Menetelmä suorasyöttöisten mikro-organismien antamiseksi siipikarjalle in ovo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |